Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial

[1]  J. Marshall,et al.  Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial , 2021, Intensive Care Medicine.

[2]  R. Bellomo,et al.  Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial , 2021, Intensive Care Medicine.

[3]  S. Bagshaw,et al.  Integration of Equipoise into Eligibility Criteria in the STARRT-AKI Trial. , 2021, American journal of respiratory and critical care medicine.

[4]  S. Besset,et al.  Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial , 2021, The Lancet.

[5]  J. Schefold,et al.  Fluid Overload and Mortality in Adult Critical Care Patients-A Systematic Review and Meta-Analysis of Observational Studies. , 2020, Critical care medicine.

[6]  R. Bellomo,et al.  Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference , 2020, Kidney international.

[7]  R. Bellomo,et al.  Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners. , 2019, Critical care medicine.

[8]  Starrt-Aki Investigators,et al.  Statistical analysis plan for the Standard versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial. , 2019, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[9]  Starrt-Aki Investigators.  STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury: Study Protocol for a Multi-National, Multi-Center, Randomized Controlled Trial , 2019, Canadian journal of kidney health and disease.

[10]  D. Annane,et al.  Timing of Renal‐Replacement Therapy in Patients with Acute Kidney Injury and Sepsis , 2018, The New England journal of medicine.

[11]  J. Marshall,et al.  Deresuscitation of Patients With Iatrogenic Fluid Overload Is Associated With Reduced Mortality in Critical Illness* , 2018, Critical care medicine.

[12]  J. Kellum,et al.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. , 2016, JAMA.

[13]  F. Tubach,et al.  Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. , 2016, The New England journal of medicine.

[14]  J. Laurila,et al.  Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study , 2012, Critical Care.

[15]  R. Bellomo,et al.  Fluid balance and acute kidney injury , 2010, Nature Reviews Nephrology.

[16]  Jonathan Himmelfarb,et al.  Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. , 2009, Kidney international.

[17]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[18]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..